CIK 0001704292 · Large accelerated filer
Zai Lab Ltd
Sign in to watch- Ticker
- ZLAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 862161632588
- Business address
- 899 HALEI ROAD, BUILDING B, PUDONG, SHANGHAI, China
- Former names
- Zai Lab Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,020
- in 1 filing, $7K under 10b5-1 plans
Net −$7,020. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Chen Yajing Chief Financial Officer | Option exercise | +920 | 36,555 | ||
| 2026-10-01 | Chen Yajing Chief Financial Officer | Shares withheld for taxes | −315 | $25.50 | $8K | 36,240 |
| 2026-10-01 | Chen Yajing Chief Financial Officer | Option exercise · Restricted Share Units | −920 | 0 | ||
| 2026-08-19 | Chen Yajing Chief Financial Officer | Sale 10b5-1 | −260 | $27.00 | $7K | 35,635 |
| 2026-08-14 | Chen Yajing Chief Financial Officer | Option exercise | +1,250 | 36,322 | ||
| 2026-08-14 | Chen Yajing Chief Financial Officer | Shares withheld for taxes | −427 | $25.90 | $11K | 35,895 |
| 2026-08-14 | Chen Yajing Chief Financial Officer | Option exercise · Restricted Share Units | −1,250 | 1,250 | ||
| 2026-08-12 | Lis William Director | Sale 10b5-1 | −8,506 | $25.00 | $213K | 41,931 |
| 2026-08-11 | Chen Yajing Chief Financial Officer | Sale 10b5-1 | −619 | $25.00 | $15K | 35,072 |
| 2026-07-02 | Du Ying Chairperson & CEO | Option exercise | +11,048 | 1,225,749 | ||
| 2026-07-02 | Du Ying Chairperson & CEO | Shares withheld for taxes | −4,348 | $19.12 | $83K | 1,221,401 |
| 2026-07-02 | Du Ying Chairperson & CEO | Option exercise · Restricted Share Units | −11,048 | 33,146 | ||
| 2026-07-02 | Du Ying Chairperson & CEO | Grant or award · Restricted Share Units | +80,393 | 80,393 | ||
| 2026-07-01 | GAYNOR RICHARD Director | Purchase 10b5-1 | +1,736 | $19.05 | $33K | 80,737 |
| 2026-07-01 | Du Ying Chairperson & CEO | Option exercise | +18,000 | 1,221,784 | ||
| 2026-07-01 | Du Ying Chairperson & CEO | Shares withheld for taxes | −7,083 | $19.15 | $136K | 1,214,701 |
| 2026-07-01 | Du Ying Chairperson & CEO | Option exercise · Restricted Share Units | −18,000 | 36,000 | ||
| 2026-06-30 | Du Ying Chairperson & CEO | Sale | −7,026 | $18.53 | $130K | 1,203,784 |
| 2026-06-29 | Du Ying Chairperson & CEO | Option exercise | +17,970 | 1,210,810 | ||
| 2026-06-29 | Du Ying Chairperson & CEO | Option exercise · Restricted Share Units | −17,970 | 17,970 |
Page 1 of 15 · 295 trades